Six of the seven tryptophan pathway genes in Bacillus subtilis are clustered in the trpEDCFBA operon (1, 5) found at 205 degrees on the B. subtilis map (36) . These genes are coordinately regulated (13) by a recently revealed, unusual mechanism (22, 41) , and the complete nucleotide sequence of the operon has been determined (12) . The seventh trp gene is not linked to this operon; it participates in both folate and tryptophan syntheses and is located near the pab gene at 10 degrees on the map (36) . This gene was originally designated trpX (18) , but here it will be called trpG to conform to the terminology used for similar amphibolic genes in Acinetobacter calcoaceticus (40) and Pseudomonas acidovorans (4) .
TrpG participates in the first step in the synthesis of tryptophan, the conversion of chorismate and glutamine to anthranilate, glutamate, and pyruvate. A reaction using the same substrates provides the p-aminobenzoate moiety for folate synthesis. Recently, it was discovered that in Escherichia coli three genes are involved in p-aminobenzoate synthesis instead of two as in anthranilate synthesis (31) . Two of the three show sequence similarities to the large and small subunits of anthranilate synthase (10, 20) ; the third, which apparently performs the final aromatization reaction, has no counterpart in anthranilate synthase. The large and small subunits of anthranilate and p-aminobenzoate synthases are related in function as well as sequence, the former binding chorismate and the latter binding glutamine (10, 20) . In each enzyme complex the large subunit can function independently, given high concentrations of ammonia and a high pH. 
MATERIALS AND METHODS
Bacterial strains and plasmids. The bacterial strains and plasmids used in this study are shown in Table 1 . Media and growth conditions. In general, B. subtilis and E. coli strains were grown on L agar or L broth (30) . For strains possessing plasmids, the following amounts of antibiotics were added unless otherwise specified: chloramphenicol (Cm), 25 jig/ml; kanamycin (Km), 25 Ixg/ml; ampicillin (Ap), 100 jig/ml; erythromycin (Em), 10 jig/ml; and sulfanilamide, 1,500 jxg/ml. Medium containing 50 ,ug of X-Gal (5-bromo-4-chloro-3-indolyl-,-D-galactopyranoside) per ml was used to detect transformants containing plasmids with an insert in the lacZ gene. GM1 and GM2 media (35) were used for transformation of B. subtilis cells.
TrpG+ transformants of B. subtilis 1A491 (a strain that contains a leaky trpG7 mutation) were recognized by growth on a medium lacking p-aminobenzoate. The selective medium (SM) contained the following substances in the proportions indicated: Bott and Wilson (BW) salts (3), 100 ml; 50% glucose, 1 ml; 1 M MgSO4, 0.1 ml; tryptophan, 2.0 mg; phenylalanine, 2.0 mg; tyrosine, 1.0 mg; and Difco purified agar, 1.5 g. Complete medium was SM supplemented with 1.0 mg of p-aminobenzoate per 100 ml. BW salts consisted of 1.24% K2HPO4, 0.76% KH2PO4, 0.1% trisodium citrate, and 0.6% (NH4)2SO4 (adjusted to pH 6.7). After transformation and before plating on SM or complete medium, cells were grown overnight in an amino acid-supplemented medium at 370C with shaking. This medium contained 100 ml of BW salts, 1.0 ml of 50% glucose, 0.1 ml of 1 M MgSO4, and 5.0 ml of BW amino acids without tryptophan. BW amino acids contained valine, lysine, threonine, glycine, aspartic acid, methionine, histidine, tryptophan, and arginine, each at 500 ,ug/ml.
Media used for testing growth requirements of the prototrophic B. subtilis 1A2 and strains containing insertionally inactivated genes are specified in the legend to Fig. 7 . Inocula for these experiments were prepared by growth in a medium containing the following substances in the proportions indicated: 100 ml of BW salts; 1 ml of 50% glucose; 0.1 ml of 1 M MgSO4; 5 ml of BW amino acids; and 1 ml of 10% yeast extract. In testing for growth requirements, it was essential before plating or inoculating broth media to wash the cells thoroughly to remove residual tryptophan and/or p-aminobenzoic acid. Cell pellets were routinely washed by repeated (10 times) suspension in the appropriate basal medium and centrifugation.
Transformation. E. coli was transformed by the method of
Cohen et al. (6) . B. subtilis was transformed as described by Piggot et al. (35) . Plasmid preparation. Plasmid DNA was prepared from 1.5-ml cultures of B. subtilis and E. coli as described by Rodriguez and Tait (38) . When the DNA was to be digested with restriction enzymes, it was treated with phenol-chloroform-isoamyl alcohol (50:48:2, vol/vol/vol) followed by chloroform-isoamyl alcohol (24:1, vol/vol) (26) (28) . Sequencing reactions were carried out by the procedure of Maxam and Gilbert (28) and developed by 8% urea-polyacrylamide gel electrophoresis by the method of Sanger and Coulson (39) . Figure 2 shows the sequencing strategy that was used. Sequence data were analyzed with the aid of the PCS computer program (24) . Amino acid sequences of the cloned genes were compared with sequences of other related proteins after appropriate alignment. Initial alignments were made by use of the FASTA program (33) . To estimate similarity between two sequences, we used the normalized alignment score of Doolittle (8) . With this method, the number of identical residues is multiplied by 10 (20 for cysteines) and the number of gaps is multiplied by -25. The score is normalized by dividing by the average length of the two sequences and multiplying by 100. Doolittle (8) presented graphic relationships between normalized alignment score and number of residues in compared sequences that permit determination of the relative certainty of relatedness.
RESULTS
Physical map of pKO101 and subcloning the two EcoRI fragments of the pKO101 insert. Figure 1 shows a physical map of pKO101, the plasmid constructed by McDonald and Burke (29) consisting of pUB110 with a 4.9-kb insert of chromosomal DNA derived from B. subtilis VB157, a sulfanilamide-resistant strain. pKO101 contains the sul gene, since transformation of the plasmid into various wild-type strains of B. subtilis rendered them resistant to sulfanilamide (29) . Figure 1 pBD9 and a kanamycin resistance gene. This fragment was subtilis 1A491 and Kmr transformants were isolated. One of isolated following agarose gel electrophoresis and used as a the transformants contained a plasmid, referred to as pJS3, vector to simultaneously clone the two fragments isolated that contained the two pKO101-derived fragments in the from pKO101. The ligation mixture was transformed into B.
same order and orientations present in pKO101. 
overlaps of all restriction sites used for labeling. Figure 2 considerable similarity to the first 75% of the sequence of the shows the sequence of the 4,880 bp plus the derived amino large subunits of p-aminobenzoate synthase from E. coli and acid sequence of the six proteins. Analysis of the pJS1 insert other enteric bacteria (10 
quence similarity to the small subunits of p-aminobenzoate synthase from enteric bacteria and the trpG products of a variety of organisms (20 (27) , and P. aeruginosa TrpE (9) (Fig. 3) . In the C-terminal half of the molecule, there are about 35% identities in at least four of the five proteins over about 250 residues. Although alignment of the proximal half of these molecules is more problematical, with <8% residue identities in at least four of the five proteins in the best alignment found, a similar result is seen with all evolutionarily diverse large p-aminobenzoate synthase subunit sequences studied (7, 19) sequenced DNA fragment (sequence coding for 162 amino acids).
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Location of the sul gene. Kane (17) reported that the order of the genes he studied was pab-trpG-sul-lysS. Thus, the sul gene should be to the right of trpG on pKO101 (Fig. 1) . Plasmid pJS4 was derived from pKO101 by deletion of the entire cloned fragment in pKO101 to the right of the EagI target site. The EagI site is only 14 bp to the right of the termination codon of trpG. When B. subtilis lA491(pJS4) was plated on SM containing sulfanilamide, no growth occurred. This confirmed the general location of the sul gene. Additional experimentation will be needed to locate it precisely. Based on sequence analysis (see above), the open reading frame immediately downstream from pabC is almost certain to be the sul gene.
Insertional inactivation ofpab, trpG, and pabC. One way to gain an understanding of the function of a gene is to inactivate it in vitro, insert it into the chromosome of a prototrophic strain by gene replacement, and determine whether growth requirements have been created. This section describes construction of plasmids containing insertionally inactivated pab, trpG, and pabC genes.
The chloramphenicol resistance (Cmr) gene of pMI1101 (34; P. Youngman, personal communication) which resides on a 1.5-kb SmaI fragment, was inserted by blunt-end ligation into the single NruI site of pJS1 that lies within the pab gene. Two plasmids were obtained by transformation of E. coli JM109: pCH1 had the Cmr fragment inserted in the pab gene in an orientation such that transcription of the Cmr gene would occur in the same direction as that of pab (Fig.  6A) ; pCH2 had the Cmr fragment inserted in the opposite orientation.
For insertional inactivation of trpG, we inserted the chloramphenicol resistance gene of pC194. The Cmr gene of pC194 resides on a 1.6-kb Clal fragment. Although trpG contains a single Clal site, there are two Clal sites in the cloned B. subtilis chromosomal DNA in pKO101 to the right of trpG (Fig. 1) . We deleted the region to the right of trpG in pKO101 by digesting with EagI and XbaI, isolating the 6.3-kb fragment, filling in the staggered ends by incubation with the Klenow fragment of DNA polymerase, and performing blunt-end ligation. The ligation mixture was transformed into B. subtilis 1A491, and selection was made for Kmr. The blunt-end ligation destroyed both the EagI and XbaI sites. This plasmid was named pJS4. The trpG gene in pJS4 was excised by cleavage with EcoRI and Aval and was inserted into pUC18 appropriately prepared by removal of the small AvaI-EcoRI fragment from the polylinker region. The resulting plasmid, pJS5, was recovered following transformation of E. coli JM109. The ClaI-ClaI fragment of pC194 containing the Cmr gene was inserted into the ClaM site of pJS5, generating pJS6 containing the insertionally inactivated trpG gene. The pJS6-containing isolate actually had two Cmr cassettes inserted into trpG (Fig. 6B) . The Cmr gene of pMI1101 was inserted into pabC. The 1.5-kb SmaI fragment of pMI1101, which contains the Cmr gene, was inserted by blunt-end ligation into the single BsshII site of pJS2 that lies within pabC. Before ligation, the BsshII-generated cohesive ends were filled in by use of DNA polymerase (Klenow fragment). Two plasmids were obtained from transformants of E. coli JM109: pCH3 had the Cmr fragment inserted in pabC in an orientation such that transcription of the Cmr gene would occur in the same direction as that of pabC (Fig. 6C) ; pCH4 had the Cmr fragment inserted in the opposite orientation.
Integration of the insertionally inactivated genes into the chromosome of a prototrophic B. subtilis strain. All of the newly constructed plasmids described in the preceding section are capable of autonomous replication in E. coli but not in B. subtilis. Each plasmid was linearized and transformed into prototrophic B. subtilis 1A2. Chloramphenicol-resistant transformants should have the insertionally inactivated genes incorporated into the chromosome. Prior to transformation of B. subtilis 1A2, pCH1 and pCH2 were linearized with SmaI. The transformants with the insertionally inactivated pab gene are referred to as B. subtilis 1A2fQpCH1 and B. subtilis 1A2QpCH2. pJS6 was linearized with BamHI. The strain with the integrated, insertionally inactivated trpG is referred to as B. subtilis 1A2fQpJS6. pCH3 and pCH4 were linearized with SmaI. The transformants with the insertionally inactivated pabC are referred to as B. subtilis 1A2fQpCH3 and B. subtilis 1A2fQpCH4.
Growth requirements of the B. subtilis strains containing pneumoniae (S.p.). Hyphens indicate gaps introduced to increase insertionally inactivated trpG, pab, and pabC genes. The inoculum for growth experiments was obtained by overnight growth in a medium containing yeast extract and tryptophan (see Methods and Materials). The cells were washed 10 times in the appropriate basal medium lacking tryptophan and p-aminobenzoic acid before use as inoculum. The compositions of the basal media used for growing each of the strains of B. subtilis are included in the legend to Fig. 7 . Figure 7A shows the growth of the prototrophic strain, B. subtilis 1A2, in (i) basal medium and in basal medium supplemented with (ii) tryptophan, (iii) p-aminobenzoic acid, and (iv) tryptophan plus p-aminobenzoic acid. No growth requirement for tryptophan or p-aminobenzoate was observed; the generation time was the same (0.67 h) in all four media. The basal medium for the above experiment contained 45 mM ammonium sulfate. No requirement for tryptophan or p-aminobenzoic acid was evident when the basal medium contained 0.45 mM ammonium sulfate (data not shown). Figure 7B shows the growth of B. subtilis 1A2fQpCH1, the strain with the insertionally inactivated pab gene, in the four media. A definite requirement for p-aminobenzoic acid and not tryptophan was evident. The generation times in basal medium plus p-aminobenzoic acid and in basal medium plus p-aminobenzoic acid plus tryptophan were about the same (1.3 h). There was also very little difference in the generation times observed for cells growing in basal medium and basal medium plus tryptophan (1.7 and 2.1 h, respectively). Es 1A2fQpCH2 (data not shown). The results were the same with both strains whether high-or low-ammonia-containing medium was used. Speculation concerning the absence of an absolute requirement for p-aminobenzoic acid in this strain is included in the Discussion. Figure 7C shows the growth of B. subtilis 1A2QlpJS6, the strain with the insertionally inactivated trpG gene, in the four media. An absolute requirement for tryptophan and a partial requirement for p-aminobenzoic acid were evident. Essentially no growth occurred in basal medium or in basal medium plus p-aminobenzoic acid. Growth did occur in basal medium plus tryptophan, but the generation time was 2.2 times longer than in basal medium plus tryptophan plus p-aminobenzoic acid (4.7 h in basal medium plus tryptophan and 2.1 h in basal medium plus tryptophan plus p-aminobenzoic acid). The basal medium for the above experiment contained 0.9 mM ammonium sulfate. When a similar experiment was conducted with a basal medium containing 45 mM ammonium sulfate, the growth was reasonably good even in basal medium (generation time, 3.0 h; data not shown). This was expected since ammonia, when present at a high concentration, can be used rather than glutamine for both the anthranilate synthase and p-aminobenzoic acid synthase reactions; i.e., glutamine amidotransferase (TrpG) is not absolutely required. The explanation for the partial (rather than complete) requirement for p-aminobenzoic acid, when 0.9 mM ammonium sulfate was present in the growth medium ( Fig. 1) , is less certain (see Discussion). Figure 7D shows the growth of B. subtilis 1A2QpCH3, the strain with the insertionally inactivated pabC gene, in the four media. A definite requirement for p-aminobenzoic acid only was exhibited. The generation time in the absence of p-aminobenzoic acid (i.e., in basal medium and in basal medium plus tryptophan) was about 7.4 h. The generation time in the presence of p-aminobenzoic acid (i.e., in basal medium plus p-aminobenzoic acid and in basal medium plus tryptophan plus p-aminobenzoic acid) was 1.8 h.
B. subtilis 1A2fQpCH3 has the Cmr cassette from pMI1101 inserted so that the Cmr gene is in the same orientation as pabC. The strain with the cassette inserted in the opposite orientation showed a definite growth defect in all media, including basal plus tryptophan plus p-aminobenzoic acid (data not shown). Perhaps the insertion affected expression of genes in the operon downstream from pabC. It is interesting that no such polarity effect was noted with the similar insertion of pCH2 into pab (data not shown).
DISCUSSION
The 4.9-kb chromosomal DNA fragment from B. subtilis that was analyzed apparently has at least six genes that are probably part of a single operon. No typical B. subtilis promoter was observed preceding pab, the first gene of the cluster. Thus, it is possible that one or more additional genes are upstream ofpab on the chromosome. Also, only a part of ORF2 is included in the cloned fragment. Thus, there may be other genes in the operon located downstream from ORF2. The distance between pab and trpG is too small (13 bp) for a promoter to be present. The other genes overlap. The apparent initiation codon of pabC precedes the termination codon of trpG by 1 bp. Similar overlaps occur between pabC and sul (19 bp), sul and ORFJ (8 bp) , and ORFJ and ORF2 The basal medium for growth of all of the strains except the one containing the insertionally inactivated trpG gene contained the following components in the proportions indicated: 100 ml of BW salts; 1 ml of 50% glucose; 0.1 ml of 1 M MgSO4; and 5.0 ml of BW amino acids without tryptophan, glycine, and methionine. The basal medium for growth of the strain containing the insertionally inactivated trpG gene contained the following components in the proportions indicated: 100 ml of low-ammonia BW salts [containing 0.012% (NH4)2SO4]; 1 ml of 50% glucose; 0.1 ml of 1 M MgSO4. The ammonium sulfate concentrations in the BW salts used in the two media were 45 and 0.09 mM, respectively. Turbidity measurements were made during growth in basal medium (0) and in basal medium supplemented with tryptophan (20 Vtg/ml) (A), p-aminobenzoic acid (10 pug/ml) (L), and both substances (*).
(4 bp). This gene arrangement strongly suggests that all of the cloned genes belong to a single operon, an operon that we refer to as a folic acid biosynthetic operon because of the nature of four of the six genes. Overlapping genes are also apparent in other operons in B. subtilis and E. coli. For example, 75% of the genes of the pur and trp operons in B. subtilis are overlapping, a situation suggesting the occurrence of translational coupling (45) .
To gain more information on the biological functions of Pab, TrpG, and PabC, the genes were insertionally inactivated and then introduced by replacement into the chromosome of prototrophic B. subtilis 1A2. Insertional inactivation of pab resulted in a partial requirement for p-aminobenzoic acid. It is uncertain why this requirement is not complete. One interesting possibility is that the anthranilate synthase large subunit (the trpE gene product) substitutes to a limited extent for Pab.
Insertional inactivation of trpG resulted in an absolute requirement for tryptophan and a partial requirement for p-aminobenzoic acid. An absolute requirement for both metabolites might have been expected, since TrpG (glutamine amidotransferase) of B. subtilis (like that of A. calcoaceticus [40] and P. acidovorans [4] ) is amphibolic, functioning in synthesis of both anthranilate and p-aminobenzoate. The partial rather than complete requirement for p-aminobenzoate may be due to partial substitution of ammonia for glutamine. Ammonia at high concentrations is known to substitute for glutamine in both enzymatic reactions.
Insertional inactivation of pabC resulted in a complete requirement for p-aminobenzoate. Nichols et al. (31) (8) for the two proteins was 219, a value indicating that the relatedness of the two proteins is probably significant. More information concerning the role of PabC in p-aminobenzoate synthesis is required before we can speculate meaningfully about the similarity between the two proteins.
Data were presented indicating that the sul gene was to the right of trpG on the cloned fragment in pKO101 (Fig. 1) . It is probable that the identification of the sul gene is correct, based on the following evidence. The amino acid sequence had significant base sequence similarity with the dihydropteroate synthase of S. pneumoniae (25) There is a logical difficulty in interpreting the results of the gene inactivation experiments discussed above. These experiments involved insertion of Cmr cassettes in the first three genes of the operon. It is theoretically possible that the phenotypes observed could be due to polarity effects on one or more downstream genes. In fact, the chloramphenicol resistance gene used does have a typical rho-independent transcriptional terminator (15) . As indicated in Results, B. subtilis 1A2flpCH2, the strain with the insertion in pabC in an orientation opposite to that of pabC, did exhibit a growth defect that was not corrected by addition of p-aminobenzoate. An effect on expression of sul, the gene immediately downstream from pabC, for example, would be expected to result in a deficiency for folic acid not corrected for by addition of p-aminobenzoate. The strain with the Cmr cassette inserted into pabC in the same orientation as pabC exhibited a growth defect correctable by p-aminobenzoate. Therefore, in this case there was no apparent polarity effect. No apparent polarity effect was observed with the strain containing the insertionally inactivated trpG gene. The requirements for tryptophan and p-aminobenzoate were observed in a low-ammonia-containing medium only, as would be expected of a trpG mutant. The phenotype resulting from inactivation of pab was a growth requirement for p-aminobenzoate only, in both high-and low-ammonia-containing media. If the phenotype was due to a polar effect on the first downstream gene, trpG, then both tryptophan and p-aminobenzoate would have been required in a low-ammoniacontaining medium.
In summary, the phenotypes observed in the gene inactivation experiments were the phenotypes expected, based on the functions we proposed for these genes. Admittedly, however, the possibility of polar effects cannot be completely ruled out. More conclusive results might be obtained by complementation studies in which the strains containing inactivated chromosomal genes are transformed with plasmids containing individual good genes corresponding to the inactivated genes.
A logical question is why polar effects of gene inactivation were not more obvious. No definite answer can be given without additional experimentation. Perhaps the transcriptional terminator at the end of the Cmr gene is not efficient and some readthrough occurs. There may be weak promoters within the operon. Another possibility is that the operon is subject to some type of antipolarity control.
As stated previously, synthesis of TrpG in B. subtilis is inhibited by tryptophan (17) . The location of the B. subtilis trpG in an apparent folate operon makes this regulation paradoxical. It does not seem reasonable that transcriptional control of the entire operon by tryptophan would occur, since this would probably cause a deficiency in p-aminobenzoate. Translational control could, presumably, be exerted on trpG without affecting expression of the other genes of the operon. A clue that translational control is likely is provided by the finding of an apparent Mtr-binding site (22, 23) between -19 and -10, with respect to the initiation codon of trpG: the sequence AGATGAGGT. Control of the trp operon of B. subtilis, the operon containing all of the tryptophan biosynthetic genes except trpG, is mediated by a regulatory protein referred to as Mtr (methyltryptophan resistance) (14) . Mtr activated by tryptophan appears to bind to the leader transcript and causes transcription termination (22) . Binding of Mtr also is believed to inhibit translation of nonterminated trpE mRNA indirectly by favoring a transcript secondary structure that sequesters the trpE ribosome-binding site (22) . The proposed Mtr-binding site overlaps with the probable trpG ribosome-binding site, GAGGTGA (Fig. 2) . Therefore, we propose that Mtr, activated by tryptophan, regulates translation of trpG mRNA by preventing binding of ribosomes to the trpG ribosomebinding site. (The possibility was mentioned above that internal promoters exist within the operon. If so, regulation by tryptophan of transcription of the operon from one promoter might not totally shut down synthesis of p-aminobenzoate.)
In summary, a 4.8-kb fragment of B. subtilis chromosomal DNA contains five complete genes and one partial gene, all of which seem to be part of a single operon. Three of these genes, pab, trpG, and pabC, are required for synthesis of p-aminobenzoate. The trpG gene is an interesting gene because its gene product is amphibolic, acting as the glutamine amidotransferase for both p-aminobenzoate synthase and anthranilate synthase. The pabC gene may encode a third polypeptide required for synthesis of p-aminobenzoate, perhaps the B. subtilis analog of enzyme X discovered in E. coli (31) . The sul gene probably encodes dihydropteroate synthase. Since at least four of the six genes of the operon are involved in folic acid biosynthesis, we feel justified in referring to the operon as a folic acid operon.
